HOME >> MEDICINE >> NEWS
Are people with HIV sticking to their medication treatment regimens? New method measures patient adherence

How do doctors know that patients are taking their medications faithfully? How can physicians help patients stay on lifesaving drugs?

In one of the most in-depth studies of its kind, UCLA researchers found that combining three measurement tools for estimating adherence to drug regimens including an electronic pill bottle cap that provides a dated record gives physicians and researchers a more accurate picture of how faithfully patients stay on their prescribed treatments than ever before.

The study, reported in the May 15 issue of the Annals of Internal Medicine, may help physicians and researchers develop new ways to measure medication adherence as well as to develop interventions to help people with HIV and other chronic diseases stay on treatment. Patient non-adherence costs the nation nearly $100 billion annually.

Researchers worked with 108 HIV-infected adults taking protease inhibitors and other highly potent drugs that suppress the HIV virus. Every month for a year, researchers compared three methods of measuring patient adherence to see which most accurately reflected how patients behaved.

The first two methods included asking patients how well they followed the treatment regimen and counting the number of pills remaining in patients medication bottles. The third method used a special pill bottle cap with a microchip that automatically recorded each time the bottle was opened.

Researchers found that combining all three methods together to generate a special composite adherence score proved more accurate than using each adherence measure by itself.

The study revealed that after taking antiretroviral drugs for six months, patients with undetectable levels of HIV were taking their medication as prescribed about 85 percent of the time. But those with detectable virus blood levels took their pills only about 66 percent of the time. Overall adherence for the full group was 76 percent.

Patient adherence to medicatio
'"/>

Contact: Rachel Champeau
rchampeau@support.ucla.edu
310-794-2270
University of California - Los Angeles
13-May-2001


Page: 1 2

Related medicine news :

1. Brain imaging study may hold clues to onset of schizophrenia in people at high risk
2. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
3. Malt liquor beers, and the people who drink them, are different
4. UCLA study shows that people drink less alcohol as they age
5. Flu vaccination benefits people of any age with high-risk medical conditions
6. Elderly people cared for by spouse are at greater risk for abuse, Pitt researchers find
7. Older people get the big picture faster, and they are less inhibited
8. Promise of bladder pacemaker for people with spinal cord injury
9. Controversial Atkins Diet may be beneficial for people with epilepsy
10. How the stories of ordinary people could give them more say over planning decisions
11. Activity not out of the question for people with chronic pain

Post Your Comments:
(Date:6/19/2013)... 2013 Weight gain and obesity have ... concerns including heart disease, kidney failure and high blood ... excess and unnecessary fat, have many people searching for ... hCG diets to not only allow patients to ... also aim to reduce the risk for many weight-related ...
(Date:6/19/2013)... To survive when your plane goes down on a combat mission, ... the most important item in a survival kit is not a ... Kleyne Hour Power of Water radio show, Orr stated that in ... ahead of guns or even food. , According to Orr, the ... carry on planes in Vietnam. He was the only Navy pilot ...
(Date:6/19/2013)... New York,NY (PRWEB) June 19, 2013 ... company officials at SizeItUp formally announced the ... This smartly renovated van is the latest entry in ... for the year 2013. The completely redesigned 2012 Nissan ... the automobile lovers and critics alike. , Provided with ...
(Date:6/19/2013)... McGuff Pharmaceuticals, Inc. continues to ... (ANDA) for Hydroxyprogesterone Caproate Injection, USP 250mg/mL, 5mL, multiple ... fomerly known as Delalutin™. We are providing this ... approval and market introduction dates for McGuff’s Hydroxyprogesterone Caproate ... our pending ANDA, to date, McGuff has responded to ...
(Date:6/19/2013)... 2013 Audibel Hearing Center is ... tinnitus patients, the A2 with Multiflex Tinnitus Technology. ... ringing in the ears. Although bothersome, tinnitus usually ... body. , Using their patent-pending Multiflex Tinnitus Technology, ... comforting sound stimulus that resonates through the patient’s ...
Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 3Health News:Vietnam Navy Pilot Reveals to Radio Host Sharon Kleyne That He Carried Extra Water Not a Gun in Survival Kit 2Health News:Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV 2Health News:Current Progress Towards ANDA Approval of Hydroxyprogesterone Caproate Injection, USP 2Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2
(Date:6/19/2013)... 19, 2013 Pharma IQ is pleased ... summary of the results from an industry survey conducted ... respondents stated that CROs would be an area of active ... be running 6 or more clinical trials in the BRIC ... Supply USA Summit explores the latest ...
(Date:6/18/2013)... , June 18, 2013 Valeant Pharmaceuticals International, ... (the "Company") announced today that VPII Escrow Corp., a ... has launched its offer of approximately $3.2 billion aggregate ... Notes will be due in 2021 and in 2023, ... Company intends to use the net proceeds from the ...
(Date:6/18/2013)... 2013  Actavis, Inc. (NYSE: ACT ) today ... U.S. Securities and Exchange Commission (SEC) a registration statement on ... Warner Chilcott plc (NASDAQ: WCRX ), which ... Chilcott (the "Form S-4"). As previously announced ... have entered into a definitive agreement pursuant to which Actavis ...
Breaking Medicine Technology:Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7
Cached News: